Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Ann Surg Oncol. 2015 Aug 28;22(Suppl 3):S985–S991. doi: 10.1245/s10434-015-4842-3

Figure 2.

Figure 2

Kaplan-Meier analysis of (A) 5-year overall survival (OS) and (B) disease-specific survival (DSS) of patients with T3N1 and different stage IV groups (T1N2, T2N2, T3N2, T4N0, T4N1 and, T4N2) disease. (C) 5-year OS and (D) DSS of patients with stage II (red line) and stage III after removal of T3N1 (blue line) disease.